-
Rationale and design of a randomized clinical trial comparing safety and efficacy of Myval transcatheter heart valve versus contemporary transcatheter heart valves in patients with severe symptomatic aortic valve stenosis: the LANDMARK trialH Kawashima, O Soliman, PW Serruys et al. -
Valve‐in‐Valve for Degenerated Transcatheter Aortic Valve Replacement Versus Valve‐in‐Valve for Degenerated Surgical Aortic Bioprostheses: A 3‐Center Comparison of Hemodynamic and 1‐Year OutcomeMC Raschpichler, F Woitek, T Chakravarty et al.
-
Coronary Access After TAVR With a Self-Expanding Bioprosthesis: Insights From Computed TomographyM Abdelghani, M Landt, H Traboulsi et al.
-
Anticoagulation After Surgical or Transcatheter Bioprosthetic Aortic Valve ReplacementT Chakravarty, A Patel, S Kapadia et al.
-
Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve ImplantationVJ Nijenhuis, J Brouwer, R Delewi et al.
-
Transcatheter Versus Surgical Aortic Valve Replacement in Low-Risk PatientsDKolte, GJ Vlahakes, IF Palacios et al.
-
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve StenosisR Waksman, PE Craig, R Torguson et al.
-
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve ReplacementGD Dangas, JGP Tijssen, the GALILEO Investigators et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
